Loading…

A dose substitution of anthracycline intensity with dose-dense rituximab in children and adolescents with good-risk mature B-cell lymphoma

Saved in:

Bibliographic Details
Published in:	Leukemia 2021-10, Vol.35 (10), p.2994-2997
Main Authors:	Goldman, Stan, Barth, Matthew, Shiramizu, Bruce, Shi, Qiuhu, Hochberg, Jessica, Klejmont, Liana, Harrison, Lauren, Basso, Jackie, Chu, Yaya, Islam, Humayun, Gerard, Perry, Agsalda-Garcia, Melissa, Shieh, Tiffany, Oesterheld, Javier, Heym, Kenneth, Kirov, Ivan, Drachtman, Richard, Harker-Murray, Paul, Perkins, Sherrie, Miles, Rodney R, Cairo, Mitchell
Format:	Article
Language:	English
Subjects:	Adolescent Adult Anthracycline Anthracyclines - administration & dosage Antineoplastic Combined Chemotherapy Protocols - therapeutic use B-cell lymphoma Chemotherapy Child Child, Preschool Children Dehydrogenases Disease prevention Dose-Response Relationship, Drug Drug dosages Drug therapy Female Follow-Up Studies Hospitals Humans Immunotherapy Lymphocytes B Lymphoma Lymphoma, B-Cell - drug therapy Lymphoma, B-Cell - pathology Male Medical schools Monoclonal antibodies Mucositis Nervous system Neutropenia Non-Hodgkin's lymphomas Pathology Pediatric research Pediatrics Prognosis Rituximab Rituximab - administration & dosage Survival Rate Targeted cancer therapy Teenagers Young Adult Young adults
Citations:	Items that this one cites Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!